Forma Therapeutics Holdings, Inc. (FMTX)

FINANCE: CORPORATE FINANCE
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

500 ARSENAL STREET WATERTOWN, MA 02472

Forma Therapeutics Holdings, Inc. operates as a biotech company. The Company develops novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Forma Therapeutics serves customers in the State of Massachusetts.

Data as of 2021-02-27 11:32:14 -0500
Market Cap1.589 Billion Shares Outstanding41.163 Million Avg 30-day Volume409.8 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-12.09 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low56.33 / 31.45 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from FMTX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 4 0.0% 4 (0.24%) 4 (0.25%) 0.0%
Funds Holding: 90 59 52.54% 36 (2.17%) 22 (1.37%) 63.64%
13F shares: 36.961 Million 27.693 Million 33.46% 24.777 Million 21.108 Million 17.39%
% Ownership 89.7898 67.2762 33.46% 60.1931 51.2775 17.39%
New Positions: 36 41 -12.2% 16 12 33.33%
Increased Positions 33 7 371.43% 11 2 450.0%
Closed Positions 4 7 -42.86% 2 4 -50.0%
Reduced Positions 9 5 80.0% 3 4 -25.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Forma Therapeutics Holdings, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding FMTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FMTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KELLY PATRICK F. CHIEF MEDICAL OFFICER

  • Officer
 77,420 2021-02-26 3

SHEGOG TODD SVP, CHIEF FINANCIAL OFFICER

  • Officer
 28,500 2021-02-26 2

COOK DAVID N SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
 63,550 2021-02-26 2

POTTS JEANNETTE SEE REMARKS

  • Officer
 70,580 2021-02-26 3

LEE FRANK D. PRESIDENT AND CEO

  • Officer
  • Director
 273,625 2021-02-26 2

WADLINGER MARY E. SEE REMARKS

  • Officer
 182,755 2021-02-26 3

VICKERS SELWYN M MD

  • Director
 0 2021-01-05 2

WIGGANS THOMAS G

  • Director
 0 2020-09-07 2

FREDERICK WAYNE A.I.

  • Director
 0 2020-07-28 2

KOLCHINSKY PETER

  • Director
  • 10% Owner
 9,011,651 2020-06-23 2

WIRTH PETER

  • Director
 0 2020-06-23 2

CLACKSON TIMOTHY P

  • Director
 0 2020-06-23 2

HALL STEVEN EDWARD

  • Director
 2,404,069 2020-06-23 2

FANUCCI MARSHA

  • Director
 0 2020-06-23 2

PAOLETTI PAOLO

  • Director
 0 2020-06-23 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

SHAH RAJEEV M.

  • 10% Owner
 9,011,651 2020-06-23 1

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

  • 10% Owner
 2,252,913 2020-06-23 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

POTTS JEANNETTE - Officer SEE REMARKS

2021-03-02 20:34:43 -0500 2021-02-26 A 14,300 a 17,700 direct

WADLINGER MARY E. - Officer SEE REMARKS

2021-03-02 20:31:10 -0500 2021-02-26 A 14,300 a 129,875 direct

SHEGOG TODD - Officer SVP, CHIEF FINANCIAL OFFICER

2021-03-02 20:28:33 -0500 2021-02-26 A 16,500 a 16,500 direct

LEE FRANK D. - Director - Officer PRESIDENT AND CEO

2021-03-02 20:23:16 -0500 2021-02-26 A 57,750 a 57,750 direct

KELLY PATRICK F. - Officer CHIEF MEDICAL OFFICER

2021-03-02 20:20:38 -0500 2021-02-26 A 16,500 a 16,500 direct

COOK DAVID N - Officer SVP, CHIEF SCIENTIFIC OFFICER

2021-03-02 20:29:38 -0500 2021-02-26 A 14,300 a 14,300 direct

POTTS JEANNETTE - Officer SEE REMARKS

2021-03-02 20:34:43 -0500 2021-02-26 A 43,550 a 43,550 direct

WADLINGER MARY E. - Officer SEE REMARKS

2021-03-02 20:31:10 -0500 2021-02-26 A 43,550 a 43,550 direct

SHEGOG TODD - Officer SVP, CHIEF FINANCIAL OFFICER

2021-03-02 20:28:33 -0500 2021-02-26 A 50,250 a 0 direct

LEE FRANK D. - Director - Officer PRESIDENT AND CEO

2021-03-02 20:23:16 -0500 2021-02-26 A 175,875 a 175,875 direct

KELLY PATRICK F. - Officer CHIEF MEDICAL OFFICER

2021-03-02 20:20:38 -0500 2021-02-26 A 50,250 a 50,250 direct

COOK DAVID N - Officer SVP, CHIEF SCIENTIFIC OFFICER

2021-03-02 20:29:38 -0500 2021-02-26 A 43,550 a 43,550 direct

POTTS JEANNETTE - Officer SEE REMARKS

2021-03-02 20:34:43 -0500 2021-02-26 A 9,330 a 27,030 direct

WADLINGER MARY E. - Officer SEE REMARKS

2021-03-02 20:31:10 -0500 2021-02-26 A 9,330 a 139,205 direct

SHEGOG TODD - Officer SVP, CHIEF FINANCIAL OFFICER

2021-03-02 20:28:33 -0500 2021-02-26 A 12,000 a 28,500 direct

LEE FRANK D. - Director - Officer PRESIDENT AND CEO

2021-03-02 20:23:16 -0500 2021-02-26 A 40,000 a 97,750 direct

KELLY PATRICK F. - Officer CHIEF MEDICAL OFFICER

2021-03-02 20:20:38 -0500 2021-02-26 A 10,670 a 27,170 direct

COOK DAVID N - Officer SVP, CHIEF SCIENTIFIC OFFICER

2021-03-02 20:29:38 -0500 2021-02-26 A 5,700 a 20,000 direct

POTTS JEANNETTE - Officer SEE REMARKS

2021-01-08 16:03:45 -0500 2021-01-06 M 3,400 a 111,746 direct

VICKERS SELWYN M MD - Director

2021-01-11 17:47:20 -0500 2021-01-05 A 25,000 a 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 20:45:03 UTC -0.271 0.341 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 20:15:03 UTC -0.271 0.341 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 19:45:03 UTC -0.271 0.341 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 19:15:02 UTC -0.271 0.341 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 18:45:03 UTC -0.2476 0.3176 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 18:15:04 UTC -0.2476 0.3176 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 17:45:02 UTC -0.2476 0.3176 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 17:15:03 UTC -0.2476 0.3176 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 16:45:03 UTC -0.2769 0.3469 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 16:15:04 UTC -0.2769 0.3469 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 15:45:03 UTC -0.2769 0.3469 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 15:15:03 UTC -0.2769 0.3469 85000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 14:45:03 UTC -0.2769 0.3469 85000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 14:15:03 UTC -0.2769 0.3469 85000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 13:45:03 UTC -0.2769 0.3469 85000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 13:15:04 UTC -0.2769 0.3469 80000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-03 12:45:03 UTC -0.2769 0.3469 75000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-02 22:15:02 UTC -0.2769 0.3469 55000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-02 21:45:03 UTC -0.2769 0.3469 55000
FORMA THERAPEUTICS HOLDINGS FMTX 2021-03-02 21:15:03 UTC -0.2769 0.3469 55000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Series Portfolios Trust- Weiss Alternative Balanced Risk Fund FMTX -36.0 shares, $-1552.32 2020-10-31 N-PORT

Elevate your investments